如何在服用抗血小板剂时进行手术:血液学家的观点
Dawn Swan1, Robert Turner2, James Douketis3
1Department of Haematology, Austin Health, Melbourne, Victoria, Australia.
Research and practice in thrombosis and haemostasis
|September 25, 2024
概括
管理需要手术的抗血小板药物患者是复杂的. 本综述提供了指导,以平衡出血和凝血风险在紧急的手术情景涉及抗血小板治疗的指导.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 手术管理的手术管理.
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡和医疗保健支出原因.
- 抗血小板药物对于二次心血管疾病预防至关重要,特别是在增加使用血管器械的情况下.
- 抗血小板治疗的一个重要并发症是出血风险增加,这对需要手术的患者构成挑战.
研究的目的:
- 提供一种临床方法来管理需要紧急手术干预的抗血小板药物患者.
- 为解决手术患者抗血小板治疗管理的强有力的指导方针的缺乏.
- 为了在这个患者群体中平衡出血和血栓事件的风险.
主要方法:
- 这是一篇综述性文章,综合了当前的证据和专家意见.
- 该方法侧重于对出血和血栓形成的风险评估.
- 考虑药物的特性,手术的紧迫性,以及患者特定的因素.
主要成果:
- 没有具体的研究结果,但概述了一个结构化的决策方法.
- 突出了抗血小板药物的禁用 (血栓形成的风险) 和继续使用 (出血的风险) 之间的困境.
- 强调基于风险分层的个性化患者管理.
结论:
- 有效的管理需要仔细考虑个体患者的风险和手术背景.
- 该审查旨在指导临床医生在做出有关停止或在手术周围继续抗血小板治疗的明智决定时.
- 需要进行进一步的研究,以确定在接受手术的患者中管理抗血小板治疗的最终指南.
关键词:
麻醉是一种麻醉.抗血小板药物可以预防血小板.阿司匹林是一种阿司匹林.流血 出血 流血 出血克洛皮多格雷尔的使用方法在此之前,Prasugrel手术 手术 手术 手术 手术 手术 手术这就是Ticagrelor.更多相关视频
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
507
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.7K
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
496
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
496
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
649
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
649
01:22Formation of the Platelet Plug
5.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.2K
01:05Introduction to Hemostasis
6.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.5K
01:24Disorders of Hemostasis
739
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
739
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K